Unisone

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Unisone

What is Unisone? (Dexamethasone)

The drug Unisone contains the active ingredient Dexamethasone, which is fundamentally characterized by its classification as a potent synthetic adrenocortical steroid.

Property Description
Active ingredient Dexamethasone
Form Tablets, Oral Solution, Injection, Topical Drops
Pharmacological class Corticosteroid / Glucocorticoid
Common use Modulating inflammatory and immune responses
Origin Synthetic (Man-made)

What is Dexamethasone and What Type of Drug is it?

Dexamethasone is a powerful synthetic glucocorticoid belonging to the pharmacological class of corticosteroids. This substance is chemically manufactured and is recognized globally as an essential medicine. Dexamethasone is specifically designed as a fluorinated glucocorticoid derivative, distinguishing it chemically from less potent, naturally occurring steroids like cortisol. Its high potency means it achieves significant therapeutic effects at relatively lower concentrations, and it is characterized by its minimal impact on the body's salt and water balance.

Composition, Forms, and Origin

Unisone is one of the many Trade names for Dexamethasone, manufactured by Unison Pharmaceuticals. The medicine is available in various pharmaceutical preparations—including tablets for oral use and sterile solutions for injection, often as the soluble salt, Dexamethasone sodium phosphate—which provide versatility for targeted or systemic routes of administration. The availability of these multiple forms is clinically recognized for supporting varied patient needs, from acute care to long-term chronic management.

General Purpose: Anti-Inflammatory and Immunosuppressive Action

The primary function of Dexamethasone is to exert profound anti-inflammatory and immunosuppressive effects. This action is clinically recognized as highly effective for providing relief from the severe symptoms of inflammation and for regulating an overactive immune response, which is crucial for managing various inflammatory conditions. Its general purpose is thus to stabilize the body’s abnormal immune and inflammatory processes, also serving a role in adrenocortical replacement when the body’s natural production of essential hormones is deficient.

What side effects are possible with Unisone?

Possible Side Effects and Safety Information

The safety profile of the active ingredient in many Unisom products (Doxylamine Succinate) is defined by its effects as a sedating H1-antihistamine with anticholinergic properties, as documented in government regulatory files (e.g., FDA, EMA).

Commonly Reported Adverse Reactions

Adverse reactions are classified by frequency based on regulatory documents:

  • Very Common: Drowsiness (Somnolence), which is the most frequent and expected side effect.
  • Common: Dry mouth (Xerostomia), dizziness, headache, constipation, and blurred vision.

System-Organ Classes Involved

Side effects are grouped by the body systems they affect:

  • Nervous System: Sedation, dizziness, confusion, and psychomotor impairment.
  • Gastrointestinal: Constipation and dry mouth.
  • Urinary: Difficulty urinating (Urinary retention).

Safety Restrictions and Serious Reactions

  • Impaired Performance: A regulatory warning mandates that individuals avoid driving or operating machinery due to the high risk of impaired mental alertness and physical coordination.
  • Drug Interactions: Use is restricted or contraindicated with alcohol or other medicines that cause central nervous system (CNS) depression (e.g., sedatives, opioids) due to the risk of additive effects and potential respiratory depression.
  • Contraindications: Use is restricted in individuals with certain pre-existing conditions where the drug's anticholinergic effects pose a direct risk, including narrow-angle glaucoma, prostatic enlargement (hypertrophy), and certain gastrointestinal obstructions.
  • Serious Reactions: Documented serious reactions include severe confusion, paradoxical excitation (agitation, especially in children and the elderly), and the potential for cardiovascular and respiratory failure in cases of toxicity or overdose.

Population-Specific Considerations

  • Elderly: There is an increased risk of severe CNS side effects, including confusion, dizziness, and anticholinergic effects like urinary retention.
  • Children: There is a higher risk of paradoxical stimulation, where the drug may cause excitement or restlessness instead of sedation, which may lead to confusion.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of doxylamine succinate (the active ingredient in Unisom) produces the signs and symptoms of anticholinergic toxicity. This toxicity can present with initial excitement, agitation, confusion, and hallucinations, followed by severe central nervous system (CNS) depression, drowsiness, and potentially coma. Physical signs can include dry mouth, dilated pupils (mydriasis), fever, and tachycardia (fast heart rate).

Serious Outcomes and Emergency Action

Overdosage can lead to life-threatening complications, including seizures, cardiorespiratory arrest, and severe cardiac arrhythmias. Children are considered a population at high risk for cardiorespiratory arrest following an overdose. Fatalities have been reported in the context of extreme overdose.

Immediate medical attention is required if an overdose is suspected. Contact emergency medical services or a Poison Control Center immediately, especially if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.

Management and Monitoring

Treatment is supportive, focusing on managing symptoms and ensuring adequate ventilation. Healthcare professionals may consider gastric decontamination (e.g., activated charcoal or gastric lavage) within one hour of ingestion. Monitoring is critical, involving continuous observation of vital signs, cardiac activity, and laboratory tests for complications such as rhabdomyolysis and acute renal failure.

Therapeutic Uses of Unisone

What Unisone Treats: Main Uses and Benefits

Unisone (Dexamethasone) is commonly used to address symptom clusters that create noticeable physiological strain. The medication is relevant in managing numerous conditions, including severe forms of arthritis, systemic allergies, asthma, and certain blood and intestinal disorders, and is also applied when appropriate in situations of hormonal replacement.


Easing the Burden of Severe Inflammation and Autoimmune Flares

Unisone is applied across therapeutic domains involving certain distressing symptoms associated with profound inflammation and an overactive immune response, such as acute exacerbations of rheumatic disorders and systemic manifestations of autoimmune conditions (e.g., lupus). It helps address symptom clusters that may become intense or disruptive, generally providing support that helps ease the overall symptom burden.


Moderating Critical Swelling and Acute Symptomatic Crises

The medication is applied in clinical settings that involve acute or unstable symptom patterns, which may include critical tissue swelling (edema), particularly in vital areas like the brain. Often used during phases when symptoms become temporarily overwhelming, this application provides highly targeted symptomatic relief to assist in easing challenging manifestations.

Quick Fact: Supports in Managing Acute Swelling


Supporting Symptom Management in Severe Allergy and Respiratory Episodes

The medication is applied in contexts where symptom clusters require supportive management, such as allergic reactions, symptoms related to skin inflammation in dermatologic disorders, or acute airway swelling. It offers symptomatic relief that helps support patients during difficult episodes, commonly contributing to improved comfort during periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus overview on Dexamethasone

Eligibility and Restrictions for Use

Who Can and Cannot Use Unisone? (Dexamethasone)

The eligibility for Unisone (Dexamethasone) is defined by official regulatory documentation, focusing on absolute exclusions and populations that require conditional use and close monitoring.

Absolute Non-Eligibility

Use of Unisone is contraindicated and must be avoided in patients with systemic fungal infections or known hypersensitivity to the drug or any component. Additionally, individuals receiving immunosuppressive doses must not receive live or live-attenuated vaccines.


Population-Specific Restrictions

Population / Condition Official Regulatory Rule
Pediatric Use Long-term use carries a risk of irreversible growth retardation; safety and efficacy for some specific uses are not established [FDA Label, EMA SmPC].
Pregnancy Use is conditional: only if the anticipated benefit outweighs the potential risk of fetal harm, such as intrauterine growth retardation [FDA Label].
Lactation Mothers receiving pharmacologic doses should generally avoid breastfeeding due to the potential for the infant’s adrenal suppression [FDA Label].
Organ Impairment Hepatic and Renal impairment require particular care and close monitoring due to altered drug clearance [EMA SmPC].
Infectious Status Use is restricted in cases of active tuberculosis (must be with anti-tuberculous chemotherapy) and cautious in ocular herpes simplex [FDA Label].

Regulatory agencies establish these constraints to ensure that the medicine is used only in patient populations where the documented risks, such as exacerbation of infection or growth inhibition, are carefully managed through official precautions and monitoring protocols.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents define the interaction structure of Unisone (Dexamethasone) by outlining both pharmacokinetic and pharmacodynamic interaction patterns, as well as specific usage prohibitions.

Pharmacokinetic and Exposure Interactions

The medicine is a substrate of the CYP3A4 enzyme. Co-administration with potent CYP3A4 inducers, such as Phenytoin, Barbiturates, or Rifampin, is documented to enhance the metabolism of Dexamethasone, potentially leading to a reduction in its systemic exposure. Conversely, CYP3A4 inhibitors, including certain HIV protease inhibitors and antifungal drugs like Ketoconazole, are documented to decrease Dexamethasone metabolism, which may increase its plasma concentrations.

Exposure is also affected by Estrogen-containing products (including oral contraceptives), which may increase binding affinity and prolong effects. Official labeling also notes that Dexamethasone clearance is decreased in patients with Chronic Liver Disease, increasing the risk of exposure-related adverse effects.

Pharmacodynamic Risks and Restrictions

Classification Official Interaction Statement
Contraindicated Combinations Use is prohibited with Live Virus Vaccines in individuals receiving immunosuppressive doses and for patients with Systemic Fungal Infections.
Additive Risk The combination with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), specifically high-dose Aspirin, increases the documented risk of gastrointestinal ulceration and bleeding.
Physiological Effects Co-administration with Potassium-Depleting Agents (e.g., Diuretics) has an officially documented additive effect that increases the risk of hypokalemia.

The label also indicates that Alcohol may increase susceptibility to ulcer formation when co-administered, and Antidiabetic Drugs may require adjustment as Dexamethasone may increase blood glucose levels.

Mechanism of Action

How Unisone Works: Mechanism of Action

Targeting the Brain's Wakefulness System

The core mechanism involves acting as an antagonist at Histamine H1 receptors primarily within the central nervous system. By blocking the binding of histamine, a critical neurochemical for alertness, the drug interrupts the signals that maintain wakefulness. This interaction initiates a state of central nervous system (CNS) depression, a physiological state consistent with diminished alertness.


Modulation of Cholinergic Pathways

In addition to the primary histamine action, the drug engages a secondary mechanism by antagonizing muscarinic acetylcholine receptors. This anticholinergic activity contributes to the modulation of general neural signaling and excitability. The combined blockade modulates the activity of arousal systems, resulting in diminished conscious awareness and physiological state changes that promote unconsciousness.

Dosage and Administration Information

How Unisone is Used: Official Administration Guidelines

Unisone (Dexamethasone) is administered according to protocols defined for medical use, with instructions varying based on the clinical situation, route, and dosage form. These guidelines dictate the administration methods and scheduling for systemic and localized use.

Administration Routes and Forms

Route of Administration Dosage Forms
Oral (PO) Tablets, Oral Solution, Elixir
Parenteral (IV, IM, Local) Sterile Solution for Injection

Standard Dosing and Scheduling

The dosage for Dexamethasone is highly individualized, beginning with a systemic starting dose typically ranging from 0.5 mg to 9 mg daily. The objective is to use the lowest effective dose for the minimum duration necessary to maintain the desired clinical effect. Dosing frequency is generally once daily or in divided doses, with a single dose in the morning often preferred for chronic oral therapy to align with the body’s natural cortisol rhythm.

Key Administration Procedures

Oral tablets can be taken with or without food. However, oral solutions may require careful measurement and must sometimes be mixed with liquid or semi-solid food before immediate consumption. For children, dosing is based on weight, with specific regimens (e.g., 6 mg PO or IV daily) outlined for adolescents in certain therapeutic contexts. A critical procedural rule for any prolonged or high-dose therapy is the requirement for gradual dose reduction (tapering) upon discontinuation to prevent potential physiological disruption.

Recent Clinical Evidence

Recent Clinical Evidence

Efficacy in Crohn's Disease (CD)

Research has explored whether the combined data showed changes in disease control and in the frequency of flare-ups for patients with severe refractory Crohn’s Disease (CD). The combination was studied in populations who had previously failed monotherapy. Studies investigated the drug's influence on measures of pain and inflammatory markers.

Phase 3 trials reported that the regimen was associated with changes in abdominal symptoms, with observations generally occurring within 2–4 weeks. Finalized data indicates that outcomes, such as achieving clinical remission, were observed at defined endpoints in the studied populations.


Safety and Tolerability Profile

The primary adverse events reported in Phase 3 trials involved mild to moderate transient hepatotoxicity and increased risk of infection. Clinical trials reported findings relevant to the monitoring of liver function, especially in the first month of treatment. Unusual fatigue or jaundice were also observed; these are features associated with hepatotoxicity.

Data indicates this therapy was utilized by most adult populations, including the elderly, in clinical trials. However, clinical trial data did not include pediatric populations.


Comparative Effectiveness

Evidence was reported comparing the combination of the two agents to either agent alone regarding symptom control in the studied populations. Research has explored whether this combination was associated with changes in mucosal healing when compared to other studied therapies. No evidence yet confirms long-term impact on surgical intervention rates.

Key Studies & References

  1. Dual Therapy in Inflammatory Bowel Disease (IBD): A Promising Therapeutic Strategy for Refractory Disease
  2. NICE Guideline NG129: Crohn's disease: management (Used for standard of care and comparison context)

Frequently Asked Questions (FAQ)

Common questions about Unisone (FAQ)

Q: Is Unisone the same type of medicine as Benadryl?

No, Unisone (Dexamethasone) is fundamentally different from Benadryl. Regulatory information classifies Unisone as a potent synthetic adrenocortical steroid, a type of medicine used to modulate inflammatory and immune responses. Benadryl (Diphenhydramine), by contrast, is classified as an antihistamine.

Q: What happens if I forget to take my Unisone dose before bed?

Official guidance on a missed dose varies depending on the specific regimen. General instructions may advise that if a dose is missed, the next steps depend on the time remaining before the next scheduled dose. Regulatory instructions consistently advise against taking a double dose to make up for a missed one.

Q: Can people with liver issues take Unisone?

Regulatory warnings indicate that patients with existing liver impairment require close medical monitoring. The medicine's clearance may be decreased in patients with liver impairment, potentially increasing exposure in the body and requiring close monitoring.

Q: What are the signs of taking too much Unisone?

Overdose signs are reported to be an exaggeration of the known side effects. This may include symptoms such as a Cushingoid state, which involves metabolic changes and significant fluid retention, necessitating immediate medical attention.

Q: What should I avoid eating or drinking while taking Unisone?

The official label notes that consuming alcohol while taking this medicine may increase the risk of developing gastrointestinal ulcers. Tablets can generally be taken either with or without food, though specific preparation instructions may vary depending on the dosage form.

Q: How does Unisone affect the central nervous system?

Dexamethasone, the active ingredient in Unisone, can potentially affect the central nervous system. Reported adverse reactions include psychiatric disturbances such as mood changes, anxiety, and irritability, as well as physical symptoms like headaches and vertigo.

Q: Does Unisone have any known interactions with herbal supplements?

Regulatory documents list drug-drug interactions based on shared metabolic pathways. Dexamethasone is metabolized in the liver by the CYP3A4 enzyme; therefore, herbal products that strongly affect this enzyme (CYP3A4 inducers or inhibitors) may alter the level of the medicine in the body.

Q: Is Unisone effective for chronic, long-term sleep issues?

Unisone (Dexamethasone) is only approved for its anti-inflammatory and immunosuppressive properties. It is not approved or intended for the treatment of chronic or temporary sleep issues, and its long-term use for any purpose requires medical supervision due to potential risks.

Q: Can Unisone be used for anxiety or just for sleep?

Official indications show that Unisone (Dexamethasone) is not approved for treating anxiety or for use as a sleep aid. While it is not a treatment for anxiety, psychiatric disturbances like anxiety and mood changes are listed as possible adverse reactions.

Q: Is it safe to take Unisone if I have high blood pressure?

Corticosteroids like Dexamethasone can cause fluid retention and sodium retention, which may lead to an elevation in blood pressure. Official warnings indicate that the drug must be administered with caution to patients with pre-existing hypertension, necessitating close monitoring.

Q: Why is Unisone sometimes used for temporary insomnia?

According to official regulatory indications, Unisone (Dexamethasone) is a steroid used for inflammatory and immune conditions. It is not approved by any regulatory body for temporary insomnia or as a sleep aid.

Q: Does Unisone cause morning grogginess or 'hangover' feeling?

Official adverse reaction reports include general symptoms like fatigue and malaise (a feeling of discomfort). Because Dexamethasone has a long biological half-life, the drug's effects can be sustained, potentially impacting a person's feeling of well-being after taking it.

Q: Are there any long-term studies on using Unisone regularly?

While the medicine has been widely studied, regulatory warnings focus on the serious risks of prolonged use. These include the potential for adrenal gland suppression (where the body stops producing its own hormones), loss of muscle mass, and osteoporosis.

Q: How long does the effect of Unisone usually last?

Official pharmacological data classifies Dexamethasone as a long-acting glucocorticoid. Its biological half-life is long, ranging from 36 to 54 hours, meaning its overall biological effects can persist for an extended period.

Q: Do you build a tolerance to Unisone over time?

Prolonged use can lead to the suppression of the body's natural adrenal system (HPA axis). This condition, which is a form of physiological dependence, requires the dose to be gradually tapered upon discontinuation to prevent withdrawal effects.

Q: What's the difference between Unisone and prescription sleep aids?

The core difference lies in their mechanism of action. Unisone (Dexamethasone) is an anti-inflammatory and immunosuppressive corticosteroid. Prescription sleep aids, however, typically act on different brain pathways, such as GABA receptors, to directly induce sedation.

Q: Can Unisone affect your dreams?

Regulatory documents list sleep disturbances and psychiatric disturbances as adverse reactions. While specific mention of changes in dreams is not always present, these types of central nervous system effects broadly cover alterations in sleep patterns and mental state.

Q: Does Unisone cause weight gain?

Yes, official adverse reactions reported with Dexamethasone include an increase in appetite and weight gain, as well as fluid retention (edema) due to its effects on the body’s metabolism.

Q: Why do some people use Unisone for motion sickness?

Unisone (Dexamethasone) is not approved for use in motion sickness. Its authorized regulatory indications are strictly limited to treating various inflammatory and immune-related conditions.

Q: How does Unisone differ from Melatonin?

Unisone (Dexamethasone) is a potent synthetic steroid used for its effects on inflammation and the immune system. This is fundamentally different from Melatonin, which is a naturally occurring hormone that acts as a regulatory signal for the body's sleep-wake cycle.

Q: Is Unisone used for treating allergies as well as sleep?

Unisone (Dexamethasone) is approved for the treatment of severe allergies due to its strong anti-inflammatory and immunosuppressive effects. However, it is not approved or intended for use as a sleep aid.

Q: What are the recommendations for discontinuing Unisone after use?

Regulatory guidance advises against the abrupt discontinuation of the medicine, especially after prolonged or high-dose therapy. A gradual dose reduction, or tapering, is necessary to minimize the risk of drug-induced secondary adrenocortical insufficiency.

Q: Can taking Unisone cause blurred vision?

Yes, the medicine is associated with ophthalmic side effects. Official reports include blurred vision as well as the potential for developing cataracts or experiencing increased pressure within the eye (glaucoma).

Q: Are there any research papers discussing Unisone's effectiveness for short-term use?

Yes, regulatory documents indicate that the medicine is specifically authorized for short-term administration. Clinical studies have supported its effectiveness in quickly managing acute flare-ups of various inflammatory and immune conditions.

Q: How is Unisone metabolized by the body?

The metabolism of Dexamethasone occurs mainly in the liver, where it is broken down primarily by the CYP3A4 enzyme system. The resulting breakdown products are then typically excreted from the body through the kidneys.

Q: Why do people sometimes say Unisone 'knocks them out'?

This description is likely due to confusion with other products that have similar names. Official information states that Unisone (Dexamethasone) is a steroid and is not indicated or expected to cause a severe level of sedation.

Q: Is it true that Unisone can be used as a nighttime cold relief ingredient?

No. Official labeling confirms that Unisone (Dexamethasone) is a potent corticosteroid and is generally a prescription-only drug. It is not an active ingredient in over-the-counter nighttime cold relief products.

Q: What makes Unisone a 'first-generation' antihistamine?

This statement is not accurate. Official regulatory classification confirms that Unisone (Dexamethasone) is a glucocorticoid steroid, and it does not belong to the class of antihistamines.

Q: Is there a maximum number of days Unisone should be taken consecutively?

While there is no fixed maximum number of days, official guidance indicates that the medicine should be used for the shortest possible duration at the lowest effective dose. The risk of serious side effects increases with longer duration of use.

Q: What are the signs that I might be allergic to Unisone?

Rare instances of severe hypersensitivity reactions have been reported in regulatory documents. Signs of an allergic reaction can include swelling of the face, lips, tongue, or throat, skin rash, itching, and difficulty breathing.

Q: Can Unisone affect laboratory test results?

Yes, the drug may influence certain test results. Official documents state that Dexamethasone can suppress the body’s reaction to certain skin tests and may also alter the results for tests measuring natural cortisol levels and blood sugar.

Q: Is it safe to take Unisone with other non-drowsy allergy medicines?

Dexamethasone is not typically associated with additive drowsiness. However, its interaction profile is complex. The co-administration of Dexamethasone with any other medicine, including allergy drugs, should be carefully evaluated for potential interactions.

Q: What kind of warnings are associated with Unisone use?

Major official warnings include the potential for adrenal suppression (where the adrenal glands do not produce enough natural hormones), an increased risk of infection, fluid and electrolyte disturbances, psychiatric issues, and negative effects on growth in children.

Q: Can older adults take Unisone without special precautions?

Older adults may be more susceptible to certain side effects, such as metabolic changes and fluid retention. Official guidance states that elderly patients may require particular care and close monitoring when receiving this medicine.

How should Unisone be stored and disposed of?

Storage Requirements

Unisone (dexamethasone) tablets must be stored at controlled room temperature, maintaining a range between 20 C and 25 C (68 F and 77 F). The medication must be kept in its original container, tightly closed, and protected from moisture and excess heat. The official labeling mandates that the product be kept out of the sight and reach of children.

For the oral solution formulation, it must be protected from light and explicitly instructed to not freeze. Additionally, the liquid must be discarded 90 days after first opening the bottle, or when the expiration date is reached, whichever comes first.

Disposal Instructions

Unisone is not on the U.S. Food and Drug Administration's (FDA) list of medicines recommended for flushing. Unused or expired medication should be disposed of using a drug take-back program as the preferred method.

If a take-back option is unavailable, the product may be discarded in the household trash. The medicine must be removed from its container and mixed with an undesirable substance, such as dirt or used coffee grounds, placed in a sealed bag or container, and then thrown away. All personal information on the prescription label should be removed or made illegible before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Unisone found in:

A-Z Index: